homevideos Newshealthcare NewsFocus back on non COVID portfolio; eyeing organic growth: Dr Lal PathLabs
Focus back on non-COVID portfolio; eyeing organic growth: Dr Lal PathLabs
Dr Lal PathLabs will be focusing on organic growth in various parts of the country, Om Manchanda, managing director, told CNBC-TV18.
Dr Lal PathLabs will be focusing on organic growth in various parts of the country, Om Manchanda, managing director, told CNBC-TV18.
“We go back to what we used to do during pre-COVID days, which is organic growth, build our network of the hub and spoke model and with the recent acquisition of Suburban Diagnostics we want to expand in the western part of India and that’s what we will continue,” he said.
He further said that with COVID-19 now receding, the focus has shifted back to the non-COVID portfolio. “Non-COVID business is sticky business, sustainable business and that’s what currently we are focusing on,” Manchanda said.
According to him, competition is much more visible now. “If you analyze data for last 10-15 years, diagnostic industry, prices have been coming down compared to inflation and that is going to happen in any case going forward as well. So, it’s not that the margins tend to drop; it’s just that scale benefits comes in, operating leverage in this business is very high. So price competitive intensity will continue to remain,” said Manchanda.
For more details, watch the video
Check out our in-depth Market Coverage, Business News & get real-time Stock Market Updates on CNBC-TV18. Also, Watch our channels CNBC-TV18, CNBC Awaaz and CNBC Bajar Live on-the-go!
BJP is planning to ban RSS, says Shiv Sena (UBT) chief Uddhav Thackeray
May 18, 2024 8:01 PM
Punjab Lok Sabha elections: Complete list of Congress candidates
May 18, 2024 4:08 PM
Punjab Lok Sabha elections: Check full list of AAP candidates and constituencies
May 18, 2024 12:59 PM
PM Modi, Rahul Gandhi election rallies in Delhi today: Here are the routes to avoid
May 18, 2024 11:28 AM